Relmada Therapeutics, Inc. (LS:A2PSZF) Financings

Relmada Therapeutics, Inc.

Financings

RaiseDate
Public offering of common stock and pre-funded warrants
Announced: about US$100M · US$2.2 a share · Jefferies +2
Dealers: Jefferies (co-lead), Leerink Partners (co-lead), Mizuho
Buyers: Janus Henderson Investors; Ferring Ventures SA; Squadron Capital Management; Marshall Wace; Spruce Street Capital; OrbiMed; Columbia Threadneedle Investments; Driehaus Capital Management
Use of proceeds: Working capital and general corporate purposes, including clinical studies and further development of product candidates
Nov 4, 2025

Read by 6ix AI from the company's releases